WallStSmart

Colgate-Palmolive Company (CL)vsStryker Corporation (SYK)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Stryker Corporation generates 22% more annual revenue ($25.27B vs $20.80B). SYK leads profitability with a 13.2% profit margin vs 10.0%. SYK appears more attractively valued with a PEG of 1.39. SYK earns a higher WallStSmart Score of 59/100 (C).

CL

Buy

58

out of 100

Grade: C

Growth: 4.0Profit: 8.5Value: 5.3Quality: 3.3
Piotroski: 3/9

SYK

Buy

59

out of 100

Grade: C

Growth: 6.0Profit: 7.0Value: 4.7Quality: 6.0
Piotroski: 3/9Altman Z: 2.18
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CLUndervalued (+16.5%)

Margin of Safety

+16.5%

Fair Value

$104.84

Current Price

$87.55

$17.29 discount

UndervaluedFair: $104.84Overvalued
SYKOvervalued (-7.6%)

Margin of Safety

-7.6%

Fair Value

$265.38

Current Price

$285.47

$20.09 premium

UndervaluedFair: $265.38Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CL3 strengths · Avg: 9.0/10
Return on EquityProfitability
36.4%10/10

Every $100 of equity generates 36 in profit

Market CapQuality
$69.90B9/10

Large-cap with strong market position

Operating MarginProfitability
20.9%8/10

Strong operational efficiency at 20.9%

SYK1 strengths · Avg: 9.0/10
Market CapQuality
$112.69B9/10

Large-cap with strong market position

Areas to Watch

CL4 concerns · Avg: 3.3/10
PEG RatioValuation
1.554/10

Expensive relative to growth rate

P/E RatioValuation
33.9x4/10

Premium valuation, high expectations priced in

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Price/BookValuation
1250.7x2/10

Trading at 1250.7x book value

SYK3 concerns · Avg: 3.7/10
P/E RatioValuation
34.0x4/10

Premium valuation, high expectations priced in

Revenue GrowthGrowth
2.6%4/10

2.6% revenue growth

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : CL

The strongest argument for CL centers on Return on Equity, Market Cap, Operating Margin.

Bull Case : SYK

The strongest argument for SYK centers on Market Cap. PEG of 1.39 suggests the stock is reasonably priced for its growth.

Bear Case : CL

The primary concerns for CL are PEG Ratio, P/E Ratio, Piotroski F-Score. Debt-to-equity of 147.93 is elevated, increasing financial risk.

Bear Case : SYK

The primary concerns for SYK are P/E Ratio, Revenue Growth, Piotroski F-Score.

Key Dynamics to Monitor

SYK carries more volatility with a beta of 0.81 — expect wider price swings.

CL is growing revenue faster at 8.4% — sustainability is the question.

CL generates stronger free cash flow (609M), providing more financial flexibility.

Monitor HOUSEHOLD & PERSONAL PRODUCTS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

SYK scores higher overall (59/100 vs 58/100). CL offers better value entry with a 16.5% margin of safety. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Colgate-Palmolive Company

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

Colgate-Palmolive Company is an American multinational consumer products company headquartered on Park Avenue in Midtown Manhattan, New York City. It specializes in the production, distribution and provision of household, health care, personal care and veterinary products.

Visit Website →

Stryker Corporation

HEALTHCARE · MEDICAL DEVICES · USA

Stryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan. Stryker's products include implants used in joint replacement and trauma surgeries; surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment; neurosurgical, neurovascular and spinal devices; as well as other medical device products used in a variety of medical specialties.

Visit Website →

Want to dig deeper into these stocks?